Retinal Disorders / AMD (continued)

The retina is the light-sensitive inner lining at the back of the eye. The retina contains millions of photo-receptors — light sensing nerve cells called rods and cones. Rods are extremely sensitive to light and dark changes, general shapes and movement, while cones are responsible for color vision and acuity.

The macula is a small region within the retina where the greatest number of cones is located. At its center is the fovea, containing only cones. Because of this high concentration of cones, the macula is critical to our ability to see color and detail.

The Human Eye

AMD Image

AMD degenerates rods and cones

In AMD, central vision is lost when the cone cells within the macula deteriorate and eventually die.

Stem cells protect rods and cones

When human neural stem cells are transplanted, photoreceptor cells — and vision — are preserved.

HuCNS-SC® Product Candidate

Optic Nerve
Pupil
Cornea
Macula
Retina (inner lining at back of eye)

HuCNS-SC Cells

Human neural stem cells, when transplanted into the sub-retinal space of animals with retinal degeneration, have been shown to protect photoreceptors from progressive degeneration and preserve visual function long-term, suggesting a promising approach to treating retinal degenerative disorders such as AMD.

Back to AMD/Retinal Disorders main page

About AMD

Currently afflicting 25-30 million people world-wide, AMD (age-related macular degeneration) results in a progressive and irreversible loss of vision. AMD is the number one cause of legal blindness for those over age 55, and the leading cause of vision loss in developed countries.

The eye contains photoreceptor cells known as rods and cones. These photoreceptors convert light into electrical impulses that are sent via the optic nerve into the brain, which then interprets what we see. Rods allow us to see under low light conditions, while cones, which require brighter light, distinguish fine detail and color. Cones are highly concentrated within the macula, a small area at the center of the retina. Because the macula is predominantly made up of cones, this area of the eye facilitates the sharp, straight-ahead vision required for such tasks as reading, driving and recognizing faces.

Patients with AMD progressively lose their clear, central vision when the cones within the macula degenerate. As of today, there is no cure for AMD.

The Bigger Picture

As the “baby boom” generation ages, the incidence of AMD is expected to increase dramatically, tripling by 2025. Photoreceptor protection through neural stem cell transplantation may be viable as a future therapy for AMD. This approach may also hold promise for treating other retinal degenerative diseases such as retinitis pigmentosa, the most common inherited cause of blindness, affecting an estimated 1.5 million people worldwide and rendering many legally blind by the age of 40.

Please Note!

You are about to open a web page or document that is hosted by a third party and is not maintained by StemCells, Inc. and to which our Privacy Policy does not apply.

This link is provided to you for convenience and does not serve as an endorsement by StemCells, Inc. of any information or contacts that you may find on this third party site.

Cancel | Continue

X